Laboratoire HRA Pharma;The United States Of America, As Represented By The Secretary, Department of Health and Human Services
发明人:
申请号：
EP16181168.2
公开号：
EP3106167A1
申请日:
2010.04.13
申请国别(地区):
EP
年份:
2016
代理人:
摘要：
The invention relates to a method for on-demand contraception, which method comprises administering a progestogen agent or progesterone receptor modulator, such as 17a-acetoxy-llb-[4-N, N-dimethylamino-phenyl)-19-norpregna- 4, 9-diene-3, 20-dione (ulipristal acetate) in a woman, within 72 hours before an intercourse or within 120 hours after the intercourse.
